Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing...

Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the...

July 2 - The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's LLY.N donanemab for patients with early Alzheimer's,...

FRIDAY, JUNE 21, 2024 -- Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of...

Fake versions of diabetes and weight loss drugs that are in high demand are being sold and advertised online. The WHO has warned people not to use...

Peter Obi, has recommended that capital punishment be handed out to drug traffickers, as a way of stemming the tide of the menace in Nigeria. Obi made...

On July 3, the Prime Minister made the following statement to Parliament on the Strategic Services Agency (SSA): Madam Speaker, I am authorised by...

The manufacturers of the most popular weight loss drugs are being challenged in court.

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...

PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of...